Evaluation of the effect of wormwood on the symptoms of premenstrual syndrome

Phase 3

Recruiting

• Conditions: Premenstrual Syndrome.; Premenstrual Syndrome; Premenstru

• Registration Number: IRCT20220311054255N1
• Lead Sponsor: Ghoum University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 2 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

Patients with premenstrual syndrome for at least one year

Exclusion Criteria

Having any menstrual disorders, pregnancy, lactation. Having diseases of the musculoskeletal system, having acute infectious diseases, especially urinary tract, having inflammatory gastrointestinal diseases and active gastric ulcer, having any Heart, liver and kidney failure and a history of major depression. Any drug addiction

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction of symptoms associated with PMS. Timepoint: Within three months. Method of measurement: Patients in two different groups are selected randomly and the drug is given to the main group and monthly symptoms are checked and telephone follow-up is done to continue taking the drug.